L'aria che tira
Screening per diabete mellito tipo 1 e celiachia: intenzioni, pregi e difetti
Screening for type 1 diabetes mellitus and coeliac disease: future plans, pros and cons
Gianluca Tornese1,2, Luigi Greco3
1IRCCS Materno-Infantile “Burlo Garofolo” Trieste
Aprile 2024 - pagg. 243 -247 | DOI: 10.53126/MEB43243
Abstract
Italy is the first country in the world to have introduced screening on the entire paediatric population for type 1 diabetes mellitus and coeliac disease. It will be preceded by a preparatory pilot study in 4 regions on approximately 5,000 children aged 2, 6 and 10 years. This article gives some practical information on the screening, the reasons for its performance and reports any possible doubts, keeping in mind the Wilson and Jungner screening criteria.
Riassunto
L’Italia è il primo Paese al mondo ad aver introdotto lo screening su tutta la popolazione pediatrica per il diabete mellito di tipo 1 e la celiachia. Sarà preceduto da uno studio pilota preparatorio in 4 regioni su circa 5.000 bambini di età compresa tra 2, 6 e 10 anni. Questo articolo fornisce alcune informazioni pratiche sullo screening, le ragioni della sua esecuzione e segnala eventuali dubbi, tenendo presente i criteri di screening di Wilson e Jungner.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Gazzetta Ufficiale della Repubblica Italiana. Legge 15 settembre 2023, n.130. GU Serie Generale n. 226 del 27-09-2023.
2. Bosi E, Catassi C. Screening type 1 diabetes and celiac disease by law. Lancet Diabetes Endocrinol 2024;12(1):12-4. doi: 10.1016/ S2213-8587(23)00354-6.
3. Istituto Superiore di Sanità. D1Ce Screen: protocollo dello studio. 06/03/2024. https://www.iss.it/en/d1ce-protocollo.
4. Ministero della Salute. Relazione Annuale al Parlamento sulla celiachia - Anno 2022.
5. Silano M, Agostoni C, Sanz Y, Guandalini S. Infant feeding and risk of developing celiac disease: a systematic review. BMJ Open 2016;6(1):e009163. doi: 10.1136/bmjopen-2015-009163.
6. Husby S, Koletzko S, Korponay-Szabó I, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr 2020;70(1):141-56. doi: 10.1097/MPG.0000000000002497.
7. van Heel DA, Hunt K, Greco L, Wijmenga C. Genetics in coeliac disease. Best Pract Res Clin Gastroenterol 2005;19(3):323-39. doi: 10.1016/j.bpg.2005.01.001.
8. Oliveira DR, Rebelo JF, Maximiano C, et al. HLA DQ2/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus. Arch Endocrinol Metab 2022;66(2):229-36. doi: 10.20945/2359-3997000000457.
9. Meijer CR, Auricchio R, Putter H, et al. Prediction Models for Celiac Disease Development in Children From High-Risk Families: Data From the PreventCD Cohort. Gastroenterology 2022;163(2):426-36. doi: 10.1053/j.gastro.2022.04.030.
10. Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect 2020;10 (2):98-115. doi: 10.34172/hpp.2020.18.
11. Birkebaek NH, Kamrath C, Grimsmann JM, et al. Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries. Lancet Diabetes Endocrinol 2022;10(11):786-94. doi: 10.1016/S2213-8587(22)00246-7.
12. Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes 2022;23(7):835-56. doi: 10.1111/pedi.13406.
13. Ghetti S, Kuppermann N, Rewers A, et al.; Pediatric Emergency Care Applied Research Network (PECARN) DKA FLUID Study Group. Cognitive function following diabetic ketoacidosis in young children with type 1 diabetes. Endocrinol Diabetes Metab. 2023 May;6(3):e412. doi: 10.1002/edm2.412.
14. Vanelli M, Chiari G, Ghizzoni L, Costi G, Giacalone T, Chiarelli F. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care 1999;22(1):7-9. doi: 10.2337/diacare.22.1.7.
15. Hummel S, Carl J, Friedl N, et al; Fr1da Study Group. Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation. Diabetologia 2023;66(9): 1633-42. doi: 10.1007/s00125-023-05953-0.
16. Herold KC, Gitelman SE, Gottlieb PA, Knecht LA, Raymond R, Ramos EL. Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function. Diabetes Care 2023;46(10):1848-56. doi: 10.2337/dc23-0675.
17. Herold KC, Bundy BN, Long SA, et al; Type 1 Diabetes TrialNet Study Group. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med 2019; 381(7):603-13. doi: 10.1056/NEJMoa 1902226. Erratum in: N Engl J Med 2020;382 (6):586.
18. Familial risk of type I diabetes in European children. The Eurodiab Ace Study Group and The Eurodiab Ace Substudy 2 Study Group. Diabetologia 1998;41(10):1151-6. doi: 10.1007/s001250051044. Erratum in: Diabetologia 1999;42(2):262.
19. Greenbaum CJ. A Key to T1D Prevention: Screening and Monitoring Relatives as Part of Clinical Care. Diabetes 2021;70(5):1029-37. doi: 10.2337/db20-1112.
20. Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 2015;38(10):1964-74. doi: 10.2337/dc15-1419.
21. Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013;309(23):2473-9. doi: 10.1001/ jama.2013.6285.
22. Whittemore R, Jaser S, Chao A, Jang M, Grey M. Psychological experience of parents of children with type 1 diabetes: a systematic mixed-studies review. Diabetes Educ 2012;38 (4):562-79. doi: 10.1177/0145721712445216.
23. Smith LB, Liu X, Johnson SB, et al; TEDDY study group. Family adjustment to diabetes diagnosis in children: Can participation in a study on type 1 diabetes genetic risk be helpful? Pediatr Diabetes 2018;19(5):1025-33. doi: 10.1111/pedi.12674.
24. Chmiel R, Giannopoulou EZ, Winkler C, Achenbach P, Ziegler AG, Bonifacio E. Progression from single to multiple islet autoantibodies often occurs soon after seroconversion: implications for early screening. Diabetologia 2015;58(2):411-3. doi: 10.1007/ s00125-014-3443-1.
25. Parikka V, Näntö-Salonen K, Saarinen M, et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 2012;55 (7):1926-36. doi: 10.1007/s00125-012-2523-3.
26. Bonifacio E, Weiß A, Winkler C, et al; TEDDY Study Group. An Age-Related Exponential Decline in the Risk of Multiple
Islet Autoantibody Seroconversion During Childhood. Diabetes Care 2021;44(10):2260–8. doi: 10.2337/dc20-2122.
27. Simmons KM, Sosenko JM, Warnock M, et al. One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes. J Clin Endocrinol Metab 2020;105(11):e4094-101. doi: 10.1210/ clinem/dgaa592.
28. Ziegler AG, Kick K, Bonifacio E, et al; Fr1da Study Group. Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany. JAMA 2020;323 (4):339-51. doi: 10.1001/jama.2019.21565.
29. Cherubini V, Chiarelli F. Autoantibody test for type 1 diabetes in children: are there reasons to implement a screening program in the general population? A statement endorsed by the Italian Society for Paediatric Endocrinology and Diabetes (SIEDP-ISPED) and the Italian Society of Paediatrics (SIP). Ital J Pediatr 2023;49(1):87. doi: 10.1186/ s13052-023-01438-3.
30. Besser REJ, Ng SM, Gregory JW, Dayan CM, Randell T, Barrett T. General population screening for childhood type 1 diabetes: is it time for a UK strategy? Arch Dis Child 2022;107(9):790-5. doi: 10.1136/archdischild-2021-321864.
31. Couzin-Frankel J. Efforts to screen kids for type 1 diabetes multiply. Science 2024;383 (6688):1164-1165. doi: 10.1126/science. adp1963.
Corrispondenza: gianluca.tornese@burlo.trieste.it